News

This was the stock's third consecutive day of losses.
In its first-quarter 2025 investor letter, Hardman Johnston Large Cap Equity Strategy highlighted stocks such as Vertex ...
The layoffs will be effective on Aug. 5, according to a letter sent to the state’s Department of Labor and Training.
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $482.4, with a high estimate of $567.00 and a low estimate of $420.00. This current average ...
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $455.45, denoting a -1% move from the preceding trading day.
According to a Worker Adjustment Retraining Notification written by Vertex to the R.I. Department of Labor and Training, ...
Vertex Pharmaceuticals is laying off 125 employees and consolidating their Rhode Island buildings after a failed diabetes ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Vertex Pharmaceuticals VRTX has outperformed the market over the past 10 years by 2.68% on an annualized basis producing an ...